GLP-1 payments
that stay open.

Payment processing built for GLP-1 weight-loss and metabolic-health clinics: semaglutide, tirzepatide, monthly protocol billing, memberships, and telehealth. Not bolted on after the fact. We audit your FDA-compliance posture and billing setup, fix the gaps, and submit a clean file so you stay approved long-term, not just on day one. Questions? Email hello@clarupay.com.

Semaglutide · Tirzepatide · Protocols Monthly programs · Multi-month packages Telehealth · Brick-and-mortar · Metabolic Within FDA guidelines · Documented need Recurring billing native Works with EHR · Telehealth · Square Card + ACH + Backup rail Semaglutide · Tirzepatide · Protocols Monthly programs · Multi-month packages Telehealth · Brick-and-mortar · Metabolic Within FDA guidelines · Documented need Recurring billing native Works with EHR · Telehealth · Square Card + ACH + Backup rail
Why GLP-1 clinics come to us

The weight-loss
incident log.

Almost every growing GLP-1 clinic has a processor horror story: a frozen account mid-month, a held payout, a protocol-billing engine that quietly breaks. We built ClaruPay to be the opposite document.

№ 001 Account flagged as pharma-adjacent Generic underwriters read semaglutide and tirzepatide as pharma-adjacent and freeze accounts without review. We know the difference between an FDA-compliant clinic and a flagged one, and structure the account so it never fires. CLOSED · FIXED
№ 002 Protocol billing broke Monthly protocols, pre-paid multi-month packages, and tiered memberships need purpose-built recurring, not duct-taped Stripe workarounds. We make recurring native. CLOSED · FIXED
№ 003 Funds held at month-end Your patients paid on time. Your cash shouldn't sit frozen in a reserve account waiting on a review while your pharmacy invoices and payroll are due. CLOSED · FIXED
№ 004 Patient disputed a package charge Descriptor mismatch drives 35 to 45% of friendly fraud, and multi-month GLP-1 packages are prime targets. When the statement name doesn't match the clinic, patients dispute. We enforce descriptor clarity and fast receipts at boarding. CLOSED · FIXED
№ 005 Support routed to a chatbot When billing breaks on a Friday night before a busy refill week, you need a person who knows your file, not a ticket queue. We answer the phone. CLOSED · FIXED
Method

How we
onboard GLP-1 clinics.

A straightforward sequence. No 90-day onboarding marathons, no "pending" states that quietly become "denied."

01Step one

Score your readiness.

Start with our free Readiness Score, a 3-minute quiz that flags your risk across FDA-compliance posture, supply documentation, subscription UX, and chargeback exposure. It tells you exactly where your clinic sits and which processors will accept it.

02Step two

Fix the gaps.

We audit your supply documentation, website claims, refund policy, and descriptor, then deliver a remediation plan. This is the work that keeps GLP-1 accounts open long-term.

03Step three

Apply with a clean file.

We match your clinic to the right processor for your compliance posture and program mix and submit a processor-ready file. The acquirer sees a well-documented, pre-audited merchant from day one.

04Step four

Stay approved.

Ongoing chargeback dashboards, VAMP ratio alerts, and processor file maintenance. Your account stays healthy, not just approved on day one.

Start application
Common questions

GLP-1
payment FAQ.

Have something specific? Email hello@clarupay.com and a real human replies within a few hours.

Generic processors flag GLP-1 clinics for a mix of reasons: semaglutide and tirzepatide read as pharma-adjacent, monthly protocol and membership billing looks like recurring high-risk, and chargeback rates on multi-month packages run above their automated thresholds. Their systems terminate first and ask questions later. We set the account up correctly from the start so the flags never fire.
Yes. Monthly protocol subscriptions, pre-paid multi-month packages, and tiered membership billing are native, with smart retry logic that recovers far more failed payments than standard processors. No Zapier glue or bolt-ons.
We support clinics operating within FDA guidelines: individualized compounding with a documented, patient-specific clinical need, and clinics using FDA-approved branded supply. We do not support mass-market compounded semaglutide or tirzepatide programs where FDA compliance cannot be documented. Our free Readiness audit tells you exactly where your clinic sits and which processors will accept it.
Yes. We handle the transition and most clinics are switched within 3 to 5 business days with no downtime. Keep the booking, EHR, or telehealth software you like; we replace only the unstable processing layer underneath it.
No. We work with GLP-1 clinics processing $20K per month and clinics processing $500K per month.
The next step

Ready for a payments partner
that knows GLP-1?

Apply online. We review your setup. You go live.

hello@clarupay.com